CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that the Company will participate in two upcoming investor conferences:
A live webcast can be accessed from the investors section of BeiGene�s websites at https://ir.beigene.com, https://hkexir.beigene.com and https://sseir.beigene.com. An archived replay will be available for 90 days following the event.
About BeiGene
BeiGene is a global biotechnology company that is developing and commercializing innovative and affordable oncology medicines to improve treatment outcomes and access for far more patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 9,000 colleagues spans five continents, with administrative offices in Beijing, China; Cambridge, U.S.; and Basel, Switzerland. To learn more about BeiGene, please visit www.beigene.com and follow us on Twitter at @BeiGeneGlobal.
Contacts
Investor
Kevin Mannix
+1-857-302-5189
ir@beigene.com
Media
Kyle Blankenship
+1 667-351-5176
media@beigene.com
TOKYO, JAPAN - Media OutReach Newswire - 7 May 2024 - Alps System Integration Co.,…
SINGAPORE--(BUSINESS WIRE)--Orbit Markets, a leading market maker of options and structured derivatives in digital assets,…
Transaction supports continuing development of high-voltage, high-power GaN technology SAN JOSE, Calif.--(BUSINESS WIRE)--Power Integrations (NASDAQ:…
WARREN, N.J. & MUMBAI, India--(BUSINESS WIRE)--$LTIM #AI--LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting…
Launched at MIT and Harvard, Multitude Insights Joins Elev X! Boost, NEC X’s Accelerator Program…
The microArch D1025 Dual-Resolution 3D Printer Delivers Flexible, High-Precision 3D Printing of Parts that Require…